A first study in the "American Journal of Pathology" the results of a treatment of Covid describes 19 patients who had received blood plasma from people who had survived this infection already. The treatment was well tolerated, and 76 percent of the patients, the condition improved.
28. March got in the USA for the first time, two critically ill patients, the Plasma of convalescent Covid-19-patients. Antibodies, which have formed the donor, to help the acutely ill to survive the infection better. Without side effects due to the Plasma transfusion the disease has improved in 19 of 25 patients, and eleven were able to be discharged from the hospital. Additional results from the study suggest that plasma therapy could be as equally effective as the anti-viral drug Remdesivir.
"While scientists around the world sought new medicines and treatments against the Covid-19-test Virus, proved to be the convalescent serum therapy as one of the most promising Strategien", Dr. James M. Musser, head of the Department of pathology and genomic medicine at the hospital of Houston Methodist said. This type of treatment was used in 1918 to combat the Spanish influenza, and even during the SARS pandemic in 2003, the Influenza H1N1-2009 pandemic and the Ebola outbreak in 2015 in Africa. After in order to achieved in the beginning of the Covid-19 pandemic in a few critically ill patients in China, an improvement has been pursued by the Team this approach in the United States.
Meanwhile, 74 seriously ill Covid were treated at the hospital 19 patients, of which 50 are already out of the hospital were dismissed. More than 150 previously infected people donated for this Plasma.